Interstitial pneumonia caused by dabigatran

Toyoshi Yanagihara; Norio Yamamoto; Yasuaki Kotetsu; Naoki Hamada; Eiji Harada; Kunihiro Suzuki; Kayo Ijichi; Yoshinao Oda; Yoichi Nakanishi

doi:10.1016/j.rmcr.2017.10.009

Interstitial pneumonia caused by dabigatran

Toyoshi Yanagihara, Norio Yamamoto, Yasuaki Kotetsu, Naoki Hamada, Eiji Harada, Kunihiro Suzuki, Kayo Ijichi, Yoshinao Oda, Yoichi Nakanishi

Research output: Contribution to journal › Article › peer-review

3 Citations (Scopus)

Abstract

We describe the case of a 73-year-old man who experienced dry cough and exertional dyspnea after dabigatran administration. Chest radiographs revealed the development of bilateral consolidative and ground glass opacity, and transbronchial lung biopsy showed organized materials in the alveolar spaces with moderate inflammatory infiltrate and focal fibrosis. Lung opacity gradually disappeared after discontinuing dabigatran. To date, there has been only one report regarding dabigatran-induced lung injury, except for alveolar hemorrhage and eosinophilic pneumonia. Therefore, we should consider that any drug can cause various types of lung injuries.

Original language	English
Pages (from-to)	10-12
Number of pages	3
Journal	Respiratory Medicine Case Reports
Volume	23
DOIs	https://doi.org/10.1016/j.rmcr.2017.10.009
Publication status	Published - 2018

All Science Journal Classification (ASJC) codes

Pulmonary and Respiratory Medicine

Access to Document

10.1016/j.rmcr.2017.10.009

Cite this

@article{08d81988002d43ce903ec5c7d3793bbb,

title = "Interstitial pneumonia caused by dabigatran",

abstract = "We describe the case of a 73-year-old man who experienced dry cough and exertional dyspnea after dabigatran administration. Chest radiographs revealed the development of bilateral consolidative and ground glass opacity, and transbronchial lung biopsy showed organized materials in the alveolar spaces with moderate inflammatory infiltrate and focal fibrosis. Lung opacity gradually disappeared after discontinuing dabigatran. To date, there has been only one report regarding dabigatran-induced lung injury, except for alveolar hemorrhage and eosinophilic pneumonia. Therefore, we should consider that any drug can cause various types of lung injuries.",

author = "Toyoshi Yanagihara and Norio Yamamoto and Yasuaki Kotetsu and Naoki Hamada and Eiji Harada and Kunihiro Suzuki and Kayo Ijichi and Yoshinao Oda and Yoichi Nakanishi",

year = "2018",

doi = "10.1016/j.rmcr.2017.10.009",

language = "English",

volume = "23",

pages = "10--12",

journal = "Respiratory Medicine Case Reports",

issn = "2213-0071",

publisher = "Elsevier BV",

}

TY - JOUR

T1 - Interstitial pneumonia caused by dabigatran

AU - Yanagihara, Toyoshi

AU - Yamamoto, Norio

AU - Kotetsu, Yasuaki

AU - Hamada, Naoki

AU - Harada, Eiji

AU - Suzuki, Kunihiro

AU - Ijichi, Kayo

AU - Oda, Yoshinao

AU - Nakanishi, Yoichi

PY - 2018

Y1 - 2018

N2 - We describe the case of a 73-year-old man who experienced dry cough and exertional dyspnea after dabigatran administration. Chest radiographs revealed the development of bilateral consolidative and ground glass opacity, and transbronchial lung biopsy showed organized materials in the alveolar spaces with moderate inflammatory infiltrate and focal fibrosis. Lung opacity gradually disappeared after discontinuing dabigatran. To date, there has been only one report regarding dabigatran-induced lung injury, except for alveolar hemorrhage and eosinophilic pneumonia. Therefore, we should consider that any drug can cause various types of lung injuries.

AB - We describe the case of a 73-year-old man who experienced dry cough and exertional dyspnea after dabigatran administration. Chest radiographs revealed the development of bilateral consolidative and ground glass opacity, and transbronchial lung biopsy showed organized materials in the alveolar spaces with moderate inflammatory infiltrate and focal fibrosis. Lung opacity gradually disappeared after discontinuing dabigatran. To date, there has been only one report regarding dabigatran-induced lung injury, except for alveolar hemorrhage and eosinophilic pneumonia. Therefore, we should consider that any drug can cause various types of lung injuries.

UR - http://www.scopus.com/inward/record.url?scp=85032886468&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85032886468&partnerID=8YFLogxK

U2 - 10.1016/j.rmcr.2017.10.009

DO - 10.1016/j.rmcr.2017.10.009

M3 - Article

AN - SCOPUS:85032886468

SN - 2213-0071

VL - 23

SP - 10

EP - 12

JO - Respiratory Medicine Case Reports

JF - Respiratory Medicine Case Reports

ER -

Interstitial pneumonia caused by dabigatran

Abstract

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this